AN INNOVATIVE TECHNICAL PLATFORM FOR THE DEVELOPMENT AND TRADE OF ANTIBODY-BASED CANCER THERAPEUTICS SUPPORTED BY DIAGNOSTIC TESTING (Q2043834): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed label, description and/or aliases in 2 languages: Changing unique label-description pair)
(‎Removed claim: financed by (P890): Directorate-General for Regional and Urban Policy (Q8361), Removing unnecessary financed by statement)
Property / financed by
 
Property / financed by: Directorate-General for Regional and Urban Policy / rank
Normal rank
 

Revision as of 08:41, 2 November 2020

Project Q2043834 in Italy
Language Label Description Also known as
English
AN INNOVATIVE TECHNICAL PLATFORM FOR THE DEVELOPMENT AND TRADE OF ANTIBODY-BASED CANCER THERAPEUTICS SUPPORTED BY DIAGNOSTIC TESTING
Project Q2043834 in Italy

    Statements

    0 references
    15,000.0 Euro
    0 references
    30,000.0 Euro
    0 references
    50.0 percent
    0 references
    25 October 2017
    0 references
    15 October 2018
    0 references
    30 December 2019
    0 references
    ARDIS S.R.L.
    0 references
    0 references

    45°11'9.60"N, 9°9'16.70"E
    0 references
    AN INNOVATIVE TECHNOLOGY PLATFORM FOR THE DEVELOPMENT AND COMMERCIALISATION OF ANTIBODY-BASED CANCER THERAPEUTICS SUPPORTED BY PRE-TREATMENT DIAGNOSTIC TESTING (Italian)
    0 references
    AN INNOVATIVE TECHNICAL PLATFORM FOR THE DEVELOPMENT AND TRADE OF ANTIBODY-BASED CANCER THERAPEUTICS SUPPORTED BY DIAGNOSTIC TESTING (English)
    0 references

    Identifiers

    E17F17000030002
    0 references